ArticleNature communications2023
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.
Ning Qing Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it